There were no significant differences in hypertension, diabetes,peripheral vascular disease, stroke, myocardial infarction, percutaneous coronaryintervention, coronary artery bypass graft, heart failure, adenosine diphosphate (ADP) receptor blocker,β-blocker, angiotensin-converting enzyme inhibitor (ACEI), angiotensinreceptor blocker (ARB), blood pressure, Killip class, ST-segment elevation,or left bundle branch block between tPM and non-tPM groups. This evidence concerns the gene ACE and diabetes mellitus.